DGCI Approves Covovax In Markets
17 Jan 2023
The Drugs Controller General of India (DCGI) has approved the official market business of Serum Institute of India's (SII) COVID-19 vaccine Covovax as a tertiary booster dose.This vaccine can be taken as a booster dose by people who have already taken two doses of Covishield or Covaxin. Last December, the...
Read More